Long-term office treatment of Meniere's disease.
D000368:Aged; D006631:Amine Oxidase (Copper-Containing) / Q000037:antagonists & inhibitors*; D001621:Betahistine / Q000008:administration & dosage; D005021:Ethylamines / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008575:Meniere Disease / Q000188:drug therapy; D008875:Middle Aged; D011725:Pyridines / Q000008:administration & dosage*
D005021:Ethylamines; D011725:Pyridines; D006631:Amine Oxidase (Copper-Containing); D001621:Betahistine